Ken O'Flynn
Portrait: © Houses of the Oireachtas (Oireachtas (Open Data) PSI Licence) · source file
Independent Ireland · Cork North-Central · serving since 2024-11-29
- Vote recorded in 265 of 401 divisions in the archive
- 401 debate contributions
- 8,242 parliamentary questions asked
Record timeline
- constituency Cork North-Central 2024-11-29 to present
- party Independent Ireland 2024-11-29 to present
written
2026-05-07 · to Health
513. Deputy Ken O'Flynn asked the Minister for Health whether any interim safeguards or escalation mechanisms are currently in place where concerns arise in relation to clinical decision-making, patient outcomes, or safeguarding in gender-related healthcare services for minors; and if so, to provide details. [33665/26]
written
2026-05-07 · to Health
516. Deputy Ken O'Flynn asked the Minister for Health whether her Department or the Health Service Executive has issued any written policy, circular, guidance, or directive since 2018 concerning the reporting, recording, or measurement of activity on a sessional basis in respect of publicly funded health services; if so, to outline the nature, scope, and status of such guidance, including the dates of issuance and the bodies to which it applies; and to provide copies of any such documents. [33669/26]
written
2026-05-07 · to Health
524. Deputy Ken O'Flynn asked the Minister for Health whether her Department has established, or intends to establish, a specific national clinical governance framework governing referrals by multidisciplinary teams for gender-related interventions funded through the treatment abroad scheme; if so, the timeline for its introduction; and if she will make a statement on the matter. [33736/26]
written
2026-05-07 · to Health
525. Deputy Ken O'Flynn asked the Minister for Health who holds ultimate policy and governance responsibility within her Department or the HSE for oversight of multidisciplinary team recommendations underpinning applications to the treatment abroad scheme for gender-related interventions; and if she will make a statement on the matter. [33737/26]
written
2026-05-07 · to Health
526. Deputy Ken O'Flynn asked the Minister for Health whether she is satisfied that the absence of a national audit or review of gender healthcare referral pathways since 2023 is consistent with her Department’s obligations in respect of clinical governance and patient safety; and if she will make a statement on the matter. [33738/26]
written
2026-05-07 · to Health
527. Deputy Ken O'Flynn asked the Minister for Health whether her Department has directed the HSE to establish structured national data collection systems in respect of gender healthcare referrals and outcomes, including those funded through the treatment abroad scheme; the timeline for same; and if she will make a statement on the matter. [33739/26]
written
2026-05-07 · to Health
528. Deputy Ken O'Flynn asked the Minister for Health what policy provisions exist to ensure the monitoring of clinical outcomes, complications, and follow-up care for patients who undergo gender-related interventions funded through the treatment abroad scheme; and if she will make a statement on the matter. [33740/26]
written
2026-05-07 · to Health
529. Deputy Ken O'Flynn asked the Minister for Health what interim governance, safeguarding, and risk management measures are currently in place pending the completion of the HSE’s updated model of care for gender healthcare services expected in Q4 2026; and if she will make a statement on the matter. [33741/26]
written
2026-05-07 · to Health
530. Deputy Ken O'Flynn asked the Minister for Health whether her Department conducted any formal policy review following publication of the final Cass Review into gender identity services in the United Kingdom; if not, the reason for same; and if she will make a statement on the matter. [33742/26]
written
2026-05-07 · to Health
531. Deputy Ken O'Flynn asked the Minister for Health whether her Department has assessed the extent to which current gender healthcare referral pathways, including those involving the treatment abroad scheme, are aligned with emerging international clinical evidence and standards; and if she will make a statement on the matter. [33743/26]
written
2026-05-07 · to Health
532. Deputy Ken O'Flynn asked the Minister for Health whether the forthcoming HSE model of care for gender healthcare services will include provisions for audit, data collection, clinical governance, and outcome monitoring; and if she will make a statement on the matter. [33744/26]
written
2026-05-07 · to Health
533. Deputy Ken O'Flynn asked the Minister for Health whether she accepts that the absence of structured data collection, national audit, and a defined clinical governance framework represents a policy gap in the oversight of gender healthcare services; and if she will make a statement on the matter. [33745/26]
written
2026-05-07 · to Health
534. Deputy Ken O'Flynn asked the Minister for Health whether her Department maintains any central record, oversight mechanism, or reporting framework in respect of reimbursement applications for high-cost or rare disease medicines, including orphan drugs; and if not, how the Department exercises policy oversight of access to such medicines. [33750/26]
written
2026-05-07 · to Health
535. Deputy Ken O'Flynn asked the Minister for Health whether any formal escalation, prioritisation, or exceptional review mechanism exists within the HSE or under her Department’s policy remit for reimbursement applications relating to rare or progressive neurological conditions, including Friedreich’s ataxia; and if she will detail the criteria and governance of any such mechanism. [33751/26]
written
2026-05-07 · to Health
536. Deputy Ken O'Flynn asked the Minister for Health the proportion of reimbursement applications for orphan or rare disease medicines that have been completed within the 180-day timeline referenced in policy agreements since 2021; and if she will provide a breakdown by year. [33752/26]
written
2026-05-07 · to Health
537. Deputy Ken O'Flynn asked the Minister for Health whether she considers it appropriate that no prioritisation framework exists within the State’s reimbursement system for life-limiting or progressive rare diseases; and whether any review of this policy position is underway.; and if she will make a statement on the matter. [33753/26]
written
2026-05-07 · to Health
538. Deputy Ken O'Flynn asked the Minister for Health whether her Department or the HSE maintains a national register or consolidated dataset of patients diagnosed with rare neurological conditions, including Friedreich’s ataxia; and if not, whether any plans are in place to establish such a dataset for service planning purposes. [33754/26]
written
2026-05-07 · to Health
539. Deputy Ken O'Flynn asked the Minister for Health whether a nationally defined clinical pathway, model of care, or designated specialist service exists for patients diagnosed with Friedreich’s ataxia; and if not, how care is currently coordinated across the State. [33755/26]
written
2026-05-07 · to Health
540. Deputy Ken O'Flynn asked the Minister for Health to clarify the current operational status of any early access or compassionate access schemes for rare disease medicines; and to confirm whether any such schemes are currently available to patients in Ireland. [33756/26]
written
2026-05-07 · to Health
541. Deputy Ken O'Flynn asked the Minister for Health the timeline, governance structure, and eligibility criteria for the proposed “sandboxed early access programme” for rare diseases referenced in the National Rare Disease Strategy 2025–2030. [33757/26]
written
2026-05-07 · to Health
554. Deputy Ken O'Flynn asked the Minister for Health to clarify which Department, agency or statutory body has responsibility for the provision of funding to community-based counselling and psychotherapy charities delivering low-cost mental health supports to the public; and if she will outline the recognised pathway by which such organisations may secure recurring State funding. [33868/26]
written
2026-05-07 · to Health
555. Deputy Ken O'Flynn asked the Minister for Health whether funding is currently available under the national mental health strategy for community-led early intervention counselling and psychotherapy services; and if she will provide details of the relevant budget lines, grant schemes or commissioning arrangements which support prevention and early intervention mental health services outside of HSE directly delivered services. [33869/26]
written
2026-05-07 · to Health
556. Deputy Ken O'Flynn asked the Minister for Health whether her Department has considered the establishment of a dedicated national funding scheme to support community-based counselling and psychotherapy charities; and if she will provide an update on any work underway in this regard. [33870/26]
written
2026-05-07 · to Health
557. Deputy Ken O'Flynn asked the Minister for Health to provide a breakdown of funding allocated in each of the past three years for community-based mental health supports in East Cork, including any funding provided to community counselling and psychotherapy providers; and if she will outline any planned service developments to address unmet need in the area. [33871/26]
written
2026-05-07 · to Health
558. Deputy Ken O'Flynn asked the Minister for Health what funding streams or supports are currently available to registered charities providing counselling and psychotherapy services to children and adolescents; and if she will outline what measures are in place to expand community-led early intervention mental health supports for young people. [33872/26]